On The Fly: Top five weekend stock stories
Catch up on the weekend's top five stories with this list compiled by The Fly: 1. The new proposal by Republicans to repeal and replace the Affordable Health Care suffered new setbacks within the party on Sunday, when Senator Ted Cruz expressed his opposition and Senator Susan Collins voiced strong criticism, according to Reuters. Senators John McCain and Rand Paul had previously said they would vote against the "Graham-Cassidy" bill, which Senate Majority Leader Mitch McConnell "intends" to put up for a vote this week, the publication noted. Publicly traded companies in the space include Aetna (AET), Anthem (ANTM), Centene (CNC), Cigna (CI), Health Net (HNT), Humana (HUM), Molina Healthcare (MOH), UnitedHealth (UNH) and WellCare (WCG). 2. This weekend, NFL teams staged a show of solidarity with protesting players by kneeling, linking arms or staying off the field during the national anthem. This comes after President Donald Trump called for owners to fire those who refuse to stand and for fans to boycott NFL games. Following the steps of former San Francisco 49ers quarterback Colin Kaepernick, who sat during the anthem last season to call attention to what he saw as a pattern of racism in the way police treats African-Americans, several NFL players have since "taken one knee" or linked arms during the playing of the national anthem. 3. Gene therapy is rapidly emerging as one of the most exciting areas in biotechnology, and generating new hope for patients with rare and often deadly inherited diseases, Andre Bary wrote in this week's edition of Barron's. The first regulatory approval for replacement gene therapy could come as soon as January, if the FDA gives the go-ahead to Spark Therapeutics (ONCE) for its one-time treatment that targets a rare, inherited retinal condition leading to blindness, he added. Other publicly traded companies developing treatments in this area include AveXis' (AVXS), Regenxbio (RGNX), Audentes Therapeutics (BOLD), and Voyager Therapeutics (VYGR). 4. "Kingsman: The Golden Circle" easily won the weekend in North America, grossing $39M from 4,003 theaters. While the sequel scored one of the best openings for the month of September, it came in somewhat behind expectations. Overseas, Kingsman 2 kicked off with $61M, for a global tally of $100M. The movie was distributed by 20th Century Fox (FOXA) and received a 51% rating on Rotten Tomatoes. 5. Oracle (ORCL), GoPro (GPRO), Xilinx (XLNX), Synopsys (SNPS), and Cadence Design (CDNS) saw positive mentions in Barron's, while Six Flags (SIX), Honda (HMC), and iRobot (IRBT) were mentioned cautiously.